Dr. Mercer received her B.S. in Chemistry at Seton Hill University in 2004 and a Ph.D. in Pharmaceutical Sciences at the University of Maryland in 2008. Her graduate training provided both breadth and depth in every phase of classical drug discovery that included organic synthesis, medicinal chemistry, pharmacology, drug metabolism, pharmacokinetics and pharmacodynamics. During her training she supervised both undergraduate and Pharm.D. students in the research laboratory and was a graduate teaching assistant for Medicinal Chemistry I and II and Physical Chemistry courses in the professional program. She joined the founding faculty of Lipscomb University College of Pharmacy in the fall of 2008 and teaches in the Pharmaceutics and Pharmacology courses and the Integrated Biomedical Sciences Laboratory. In addition to her work with Lipscomb University, Dr. Mercer is an Adjunct Assistant Professor in the Department of Pharmacology at Vanderbilt University and a member of the Vanderbilt Institute of Chemical Biology. Dr. Mercer is currently collaborating with Drs. Eric Skaar and Alex Waterson on the design and development of novel inhibitors for anthrax and staph bacteria. Additional research interests include the design and synthesis of novel opioid analgesics with reduced side effects. Dr. Mercer is published in the medicinal chemistry and pharmacology literature and serves as a manuscript reviewer for Bioorganic and Medicinal Chemistry Letters and Current Medicinal Chemistry. She has been the recipient of various awards including a Leadership Development Award from the ACS Younger Chemists Committee (2008) and has been recognized by Seton Hill University as a Distinguished Recent Alumni (2009). Dr. Mercer also serves her profession as the Secretary/Treasurer for the Drug Design and Discovery Section of the American Association of Pharmaceutical Scientists.